Vimal Mehta | CEO |
Richard Steinhart | CFO |
Frank Yocca | Chief Scientific Officer |
Vincent O'Neill | SVP & Chief Medical Officer |
Andrea Brettler | UBS |
Edward White | H.C. Wainwright |
Good morning, and welcome to BioXcel Therapeutics Second Quarter 2019 Earnings Conference Call and Audio Webcast.
Before we start, I would like to inform you that this conference is being recorded and that all participants are in listen-only mode. At the request of company we will open the conference up for question and answers after the presentation. [Operator Instructions]
Just to remind everyone, certain matters discussed in today's conference call or answers that may be given to questions asked are forward-looking statements that are subject to risks and uncertainties relating to future events and/or the future financial performance of the company.